Evaluate efficacy and safety of prophylactic antibiotics in preventing early ventilator-associated pneumonia
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
100
Beta lactam cefipim infusion (20mg/kg -12h -2 days ) total volume 10 ml
Patient will receive .9 % saline (10ml /12h/2days)
Benha university hospital
Banhā, Al-Qalyubia, Egypt
Ventilation associated pneumonia
The primary outcome is the proportion of patients who will develop VAP (radiology, TLC, temperature, hemodynamic, sputum culture )from the 2nd to the 7th day of mechanical ventilation
Time frame: from the 2nd to the 7th day of mechanical ventilation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.